***** MannKind: Afrezza Scripts Approach 300; Trajectory Is Still Low Sep. 26, 2016 3:16 AM ET Spencer Osborne •Total scripts came in at about 300. •The sales trajectory is more modest than needed. •Financial and listing events weigh on the stock. http://seekingalpha.com/article/4008360-mannkind-afrezza-scripts-approach-300-trajectory-still-low?app=1&auth_param=1vat:1buhh2l:29f01dc52471065fd33bfbd54e3c6896&uprof=51#alt1